{"nct_id":"NCT02393248","title":"Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)","status":"TERMINATED","status_verified_date":"2022-12","start_date":"2015-02-27","start_date_type":"ACTUAL","primary_completion_date":"2021-12-17","primary_completion_date_type":"ACTUAL","completion_date":"2021-12-17","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["INCY"]}